14.15MUSD
Type
Common Stock
Exchange
OTCQB
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US68621D2062
CUSIP
-
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
October
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
-0.05
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.78
Wall Street Target Price
-
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
5,555,000
Gross Profit TTM
4,534,000
EBITDA
-4,937,000
Profit Margin
-92.35%
Return On Assets TTM
-152.00%
Return On Equity TTM
0.00%
Revenue Per Share TTM
0.844
Qtly Revenue Growth YOY
32.70%
Diluted Eps TTM
-0.78
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
2.5481
Price Book MRQ
21.7983
Enterprise Value Revenue
2
Enterprise Value EBITDA
0
310.09
6.14%17.44
2.11%297.69
1.89%55.63
1.40%151.74
1.05%616.18
0.79%445.77
0.63%884.00
0.18%885.00
0.00%67.55
-4.40%